Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly (NY: LLY ) 883.33 +16.03 (+1.85%) Official Closing Price Updated: 7:00 PM EDT, Jun 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Eli Lilly < Previous 1 2 3 4 5 6 7 8 9 10 Next > Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises June 11, 2024 EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety Hims & Hers Health Soars on Generic GLP-1 Rollout Plans June 03, 2024 Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments Via MarketBeat Study Questions Serious Flaws in $35 Million Antidepressant Research March 22, 2024 CCHR says millions of taxpayer dollars are wasted on psychotropic drug research later found to be flawed and harmful to consumersLOS ANGELES - March 22, 2024 - PRLog -- Researchers have reanalyzed data... Via PRLog Topics Fraud Exposures Legal Product Safety Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises June 11, 2024 From FN Media Group LLC Via GlobeNewswire 4 Stocks Making New Highs Despite Market Weakness June 03, 2024 While the market faced challenges on Friday, Birkenstock, NetApp, Eli Lilly, and Aflac showed notable strength by achieving new 52-week highs. Via MarketBeat LifeMD Can Surge on Its GLP-1 Offerings May 28, 2024 LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result Via MarketBeat CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study May 23, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study May 23, 2024 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property MarketBeat Week in Review – 5/6 - 5/10 May 11, 2024 Sell in May, then go away got pushed to the side this week, but the bearish sentiment could return when investors get the latest read on inflation next week. Via MarketBeat Topics Economy Exposures Interest Rates Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions May 08, 2024 Via AB Newswire Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections" May 07, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections" May 07, 2024 SAN DIEGO, CA - (NewMediaWire) - May 07, 2024 - Sigyn Therapeutics, Inc. (“Sigyn Therapeutics”, “Sigyn” or the “Company”) (OTCQB: “SIGY”), a development-stage medical technology company, announced... Via TheNewswire.com Exposures COVID-19 Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon May 06, 2024 Eli Lilly stock continues to move higher after the company reported continuing momentum for its flagship GLP-1 weight loss drugs Via MarketBeat 3 Staples Stocks to Cushion Lower Consumer Sentiment May 02, 2024 Three stocks in the consumer staples sector could come to save investor portfolios from potential underperformance following sentiment contractions Via MarketBeat Topics Economy Exposures Economy MarketBeat Week in Review – 4/22 - 4/26 April 27, 2024 Investors continue to look for clarity as tech earnings sent stocks higher to end the week, even as investors hope for rate cuts fade as inflation rises Via MarketBeat Topics Economy Exposures Economy Interest Rates Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs? April 22, 2024 The GLP-1 weight loss trend continues to flourish, and the ante keeps rising; see how the winner between Wegovy and Zepbound can help your portfolio Via MarketBeat 6 Stocks Positioned to Soar as Investors Focus on MASH April 22, 2024 Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of... Via TheNewswire.com Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM) April 18, 2024 Via AB Newswire Topics Economy Exposures Interest Rates Novo Nordisk Arms Wegovy to Be a Triple Threat April 15, 2024 Novo Nordisk has had success with Ozempic and Wegovy for Type 2 diabetes and obesity, seeks to expand indications to include cardio diseases and neuro disorders Via MarketBeat Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 09, 2024 Altimmune has a GLP-1 candidate in Phase 2 trials, but the company continues to burn cash and may need a big pharma partner to get its drug to market Via MarketBeat Exposures Product Safety Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs? April 08, 2024 Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend Via MarketBeat Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill April 03, 2024 Viking Therapeutics is preparing to be the next entry into the GLP-1 Market, and VKTX stock is soaring as analysts start to bid the stock higher Via MarketBeat Exposures Product Safety DexCom Stock Gains from GLP-1 Diabetic Users April 02, 2024 DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People Via MarketBeat 7 Stocks That Will Drive the Weight Loss Drugs Market March 28, 2024 The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. Via MarketBeat Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer March 24, 2024 Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM March 22, 2024 Via Press Release Distribution Service Topics ETFs LifeMD Shares Come Back to Life on GLP-1 Business Growth March 19, 2024 LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 Via MarketBeat Can WeightWatchers Regain its Mojo after Oprah Steps Down? March 13, 2024 WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). Via MarketBeat MarketBeat Week in Review – 3/4 – 3/8 March 09, 2024 The market rally continues as the February Jobs Report reignited the soft landing talk, but momentum could stall if next week's inflation readings come in hot Via MarketBeat Topics Artificial Intelligence Economy Exposures Artificial Intelligence Interest Rates BenevolentAI CEO Dr Joerg Moeller discusses AI's impact on drug discovery March 08, 2024 BenevolentAI CEO Dr Joerg Moeller tells Proactive's Stephen Gunnion how the company is positioning itself as a pioneer in AI-augmented drug discovery, aiming to enhance the success rates of drug... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.